Detalhe da pesquisa
1.
Glucagon in type 2 diabetes: Friend or foe?
Diabetes Metab Res Rev
; 39(3): e3609, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36637256
2.
Professional continuous glucose monitoring in patients with diabetes mellitus: A systematic review and meta-analysis.
Diabetes Obes Metab
; 25(5): 1301-1310, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36661362
3.
Effectiveness and safety of GLP-1 receptor agonists versus SGLT-2 inhibitors in type 2 diabetes: an Italian cohort study.
Cardiovasc Diabetol
; 21(1): 162, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35999556
4.
Reduction of hypoglycaemia, lifestyle modifications and psychological distress during lockdown following SARS-CoV-2 outbreak in type 1 diabetes.
Diabetes Metab Res Rev
; 37(6): e3404, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32918324
5.
Sodium-glucose co-transporter-2 inhibitors and protection from cardiovascular death: Is it all about heart failure?
Diabetes Obes Metab
; 23(9): 2194-2196, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34033214
6.
The diabetic lung: An easy target for SARS-CoV-2?
Diabetes Metab Res Rev
; 36(8): e3346, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32426928
7.
Renal effects of GLP-1 receptor agonists and tirzepatide in individuals with type 2 diabetes: seeds of a promising future.
Endocrine
; 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38472620
8.
Glucometabolic outcomes of GLP-1 receptor agonist-based therapies in patients with type 2 diabetes: a systematic review and network meta-analysis.
EClinicalMedicine
; 64: 102181, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37719418
9.
SGLT-2 inhibitors as cardio-renal protective agents.
Metabolism
; 127: 154937, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34808144
10.
Cardiovascular and Renal Effectiveness of GLP-1 Receptor Agonists vs. Other Glucose-Lowering Drugs in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Real-World Studies.
Metabolites
; 12(2)2022 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35208256
11.
Mini Review: Effect of GLP-1 Receptor Agonists and SGLT-2 Inhibitors on the Growth Hormone/IGF Axis.
Front Endocrinol (Lausanne)
; 13: 846903, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35265043
12.
Role of Glucose-Lowering Medications in Erectile Dysfunction.
J Clin Med
; 10(11)2021 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34198786
13.
Titratable fixed-ratio combination of insulin glargine plus lixisenatide: A simplified approach to glycemic control in type 2 diabetes mellitus.
Diabetes Res Clin Pract
; 170: 108478, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33002548
14.
Differential indication for SGLT-2 inhibitors versus GLP-1 receptor agonists in patients with established atherosclerotic heart disease or at risk for congestive heart failure.
Metabolism
; 104: 154045, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31821814
15.
Heterogeneity and Similarities in GLP-1 Receptor Agonist Cardiovascular Outcomes Trials.
Trends Endocrinol Metab
; 30(9): 578-589, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31401015
16.
Diabetes and cancer: Pathophysiological fundamentals of a 'dangerous affair'.
Diabetes Res Clin Pract
; 143: 378-388, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29679627
17.
GLP-1 Receptor Agonists for Cardiovascular Protection: A Matter of Time.
Diabetes Care
; 45(2): e30-e31, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35020816
18.
Commentary: Glucose control: Not just a bystander in GLP-1RA-mediated cardiovascular protection.
Metabolism
; 109: 154272, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32470349
19.
Diabetes in the Time of COVID-19: A Twitter-Based Sentiment Analysis.
J Diabetes Sci Technol
; 14(6): 1131-1132, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32762346